hydroxyl radical has been researched along with 2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone in 1 studies
| Studies (hydroxyl radical) | Trials (hydroxyl radical) | Recent Studies (post-2010) (hydroxyl radical) | Studies (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone) | Trials (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone) | Recent Studies (post-2010) (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone) |
|---|---|---|---|---|---|
| 10,147 | 26 | 3,657 | 31 | 2 | 5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Begleiter, A; Hasinoff, BB | 1 |
1 other study(ies) available for hydroxyl radical and 2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone
| Article | Year |
|---|---|
The reductive activation of the antitumor drug RH1 to its semiquinone free radical by NADPH cytochrome P450 reductase and by HCT116 human colon cancer cells.
Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Cell Line, Tumor; Cell Proliferation; Colonic Neoplasms; Electron Spin Resonance Spectroscopy; Humans; Hydrogen Peroxide; Hydroxyl Radical; Iron; Molecular Structure; NADPH-Ferrihemoprotein Reductase; Oxidation-Reduction; Quinones | 2006 |